News
Fintel on MSN14h
Ladenburg Thalmann Downgrades Artivion (AORT)
Fintel reports that on August 13, 2025, Ladenburg Thalmann downgraded their outlook for Artivion (NYSE:AORT) from Buy to ...
Discover insights from NeuroOne Medical Technologies (NMTC)'s Q3 2025 earnings call, featuring 105% revenue growth, new clinical milestones, and ...
Ronald W. McClurg, CFO, said, "product revenue increased 105% to $1.7 million" and cited "sizable improvements year-over-year ...
Artivion’s second quarter was marked by significant product momentum, as robust sales of On-X mechanical heart valves and ...
Barchart on MSN3h
Lucid Motors Is Caught in a Tariff Trap. Is LCID Stock More Likely to Hit $1 or $7 in 2025?
Electric vehicle (EV) stocks have had a turbulent run over the past year, as production delays, rising costs, and shifting trade policies shake up the sector. This time, Lucid Group (LCID) now finds ...
Jeffrey Scott Cohen - Ladenburg Thalmann & Co. Inc., Research Division ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback